And to further add obscurity to this issue of ROSG's scientific value..........I personally know nothing regarding the decision to allow some funds to pay for their tests, as the bar is set so low for anything which may be effective, therefore in my opinion the value of jumping a single hurdle is immeasurable......better likelihoods may now foster the view that in the short term ROSG has escaped bankruptcy.
so...as i'm reading u...this is good for "us", in that "we" can identify those unsuspected cells coming from other places?
one thing neat i read is that a lot of cancer drugs are moving towards very site specific, organ specific treatment, as opposed to just pumping u full of poisons which kill everything, and so it kind of helps, haha, for the doc to know where in the body to go.
Market Data 
Markets 
AI
